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In a recent clinical trial we demonstrated the analgesic effects of anodal transcranial direct current
stimulation (tDCS) in patients with spinal cord injury (SCI); however, the positive impact of tDCS
on pain was not paralleled by an improvement in quality of life or other related clinical scales.
Here we discuss the reasons of such negative results and present hypotheses that could explain why
tDCS had no impact on patients’ quality of life, while their average level of pain decreased. We will
also discuss how these negative findings can help to design future clinical trial using tDCS to treat
individuals with chronic pain.
tDCS is an alternative but relevant therapeutic option to manage pain and stimulate motor
recovery in patients with SCI. This non-invasive neuromodulation technique has been shown to
significantly and sustainably reduce pain if applied repeatedly in various pain syndromes (Fregni
et al., 2006a,b; Valle et al., 2009; Sakrajai et al., 2014; Castillo-Saavedra et al., 2016). In our previous
study we assessed the effects of motor (M1) anodal tDCS on pain relief, as well as satisfaction with
life as measured by the Satisfaction with Life Scale (SWLS) (Diener et al., 1985; Dijkers, 1999),
quality of life through mental state (Kroenke et al., 2001) with the Patient Health Questionnaire
(PHQ-9), and symptoms of depression with the Beck Depression Inventory. The study comprised
two phases; the first one consisted of five tDCS sessions with behavioral assessments completed at
baseline, at the end of the five stimulation sessions, at 1-week and 3-month follow-up. The second
phase started after the end of the 3-month follow-up period of the Phase I. During this second
phase, patients who agreed to continue received 10 sessions of tDCS (applied once daily for 2 weeks)
in order to evaluate the effects of adding a second phase of treatment. Assessments were performed
after 5 and 10 stimulation sessions and at 2, 4, and 8-week follow-up. While pain was found to be
reduced in the active treatment group, and this effect was maintained up to 4 weeks after the last
tDCS session, quality of life and mood remained unchanged throughout the entire duration of the
protocol for both active and sham groups.
Several hypotheses could explain why anodalM1 tDCS had no influence onmood or satisfaction
with life: (1) M1may not be an appropriate target to modulate mood or satisfaction with life; (2) the
primary outcome was pain and therefore this study was not designed to specifically detect change
in such scales; (3) the SWLS and PHQ-9 may not be accurate or sensitive enough to detect changes
due to tDCS treatment.
Based on the current tDCS literature and the present understanding of pain sensitization
mechanisms, the sensorimotor cortex is the most relevant area to target when aiming at treating
pain (Castillo Saavedra et al., 2014). By stimulating this specific brain region, anodal tDCS can
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reduce or reverse the detrimental reorganization of the neural
pain network occurring as a consequence of chronic pain
mechanisms (Seifert and Maihöfner, 2009; Henderson et al.,
2011; Gustin et al., 2012). Several studies have shown that
M1 stimulation, using either tDCS or other non-invasive brain
stimulation techniques such as transcranial magnetic stimulation
(TMS), leads to local and distant neural effects that result in
pain reduction (Lefaucheur, 2016). For instance, stimulating
M1 may counteract the lack of inhibition from M1, that could
also be associated with pain reduction (Botelho et al., 2016;
Caumo et al., 2016). In addition, neuroimaging studies have
demonstrated that tDCS could also induce changes in thalamic,
insula and cingulate activity (Yoon et al., 2014; Simis et al.,
2015), known to be related to pain processing (Treede et al.,
1999). Regarding quality of life and life satisfaction, significant
improvements have been observed when tDCS was applied over
the dorsolateral prefrontal cortex (DLPFC), rather than M1
stimulation, in various conditions (Fregni et al., 2006b; Mori
et al., 2011; Viana et al., 2014; Liu et al., 2016). Indeed, the
prefrontal region has been shown to be a better modulator for
mood, and quality of life (Schaffer et al., 1983; Drevets, 1998).
The region of interest, and subsequently the network to target, is
one of the most important parameters when designing a clinical
trial, based on the symptoms or behaviors to improve. In this
context it is essential to evaluate the brain behavior relationship
with the appropriate tools when designing a clinical trial. This can
be seen as a decisional pyramid between: symptom(s)—network
to target—behavioral correlates. In this context it is critical to
have a clear a priori hypothesis and to select the appropriate
clinical scale(s) accordingly. A recent framework developed by
researchers from National Institute of Mental Health (NIMH),
called the research domain criteria (RDoC) is useful for such
analysis.
Sankarasubramanian et al. (2017) assessed the effects of anodal
tDCS applied on two distinct sites on functional connectivity.
They found site-specific effects of M1 tDCS vs. tDCS applied
over the DLPFC on functional connectivity between the
thalamus and the cortex. Both M1 and DLPFC tDCS increased
functional connectivity between the ventroposterolateral nucleus
of the thalamus and the sensorimotor cortices; however, the
connectivity was greater with M1 tDCS. On the other hand,
both M1 and DLPFC tDCS increased functional connectivity
between the medial dorsal nucleus of the thalamus and the motor
cortex, but only DLPFC tDCS modulated functional connectivity
between this nucleus and affective cortices (Sankarasubramanian
et al., 2017); highlighting the network-specific effect of site-
specific tDCS. From a clinical perspective, similar observations
have been made. Roizenblatt et al. (2007) compared the effects
of anodal tDCS applied over the left DLPFC with M1 tDCS on
pain level and sleep in patients with fibromyalgia (Roizenblatt
et al., 2007). M1 stimulation was the only condition associated
with reduced pain, and it improved sleep quality as well. On
the other hand, DLPFC tDCS did not modulate pain level
and it worsened sleep efficiency, stressing the site-specificity of
tDCS clinical effects. In addition Boggio et al. (2008) showed
that in healthy subjects only M1 stimulation leads to a change
of somatosensory perception (Boggio et al., 2008). Indeed, it
appears than stimulating M1 mainly influences lateral thalamic
projections that process sensory-discriminative information and
are paralleled with significant clinical improvement (Antal
et al., 2010; Mori et al., 2010), while the stimulation of other
sensorimotor structures, such as the somatosensory cortex or the
premotor, and supplementary motor areas, have failed to induce
similar analgesic effects (Koyama et al., 1993; Hirayama et al.,
2006).
Recently, the authors of a randomized controlled trial, notably
arguing that they had performed the first and only sufficiently
powered trial testing the analgesic effects of tDCS in participants
with SCI, concluded that anodal M1 tDCS was ineffective to
alleviate or reduce pain in this specific condition when applied
for 5 days (Luedtke et al., 2015). In this trial, they compared
a group of patients receiving active tDCS for 5 days followed
by cognitive training for 4 weeks, to a group of patients who
received sham tDCS for 5 days followed by the same cognitive
training for 4 weeks. However, such results need to be assessed
with caution given that themain area of stimulation (i.e., M1) and
the behavioral training that was performed following tDCS (i.e.,
cognitive behavioral therapy) targeted two different networks.
The authors found a significant decrease in pain scores in both
groups (sham and active M1 tDCS) after cognitive behavioral
therapy, but there were no differences between active and sham
tDCS. This result is not surprising since the cognitive behavioral
therapy activates mainly prefrontal neural circuits, while M1
tDCS stimulates the sensori-motor network. In this case, an
important concept needs to be considered when designing a
protocol; it is not only the anatomical region of stimulation
that needs to be determined but the anatomical region plus the
cortical engagement. For instance, if M1 is targeted with tDCS
but a behavioral stimulation activates prefrontal circuits, it is
expected that M1 tDCS would have minor, or no effects at all, on
enhancing the effects of behavioral stimulation since they target
two different circuits. It is suggested that combined therapies
should target the same circuit to be additive. Indeed, tDCS could
prime the brain targeted circuit before a therapy as it has been
shown with combined tDCS and robotic upper limb therapy in
cerebral palsy (Friel et al., 2017).
As noted above, it is essential to understand the mechanisms
and networks involved in a specific pathology in order to
appropriately treat it. It is now well-acknowledged that tDCS
modulates not only the area stimulated but also the entire
neural network. For instance, by means of neuroimaging studies
(fMRI and Positron Emission Tomography—PET-scan), anodal
M1 tDCS has been shown to activate ipsilateral motor areas
(e.g., primary, supplementary, or premotor cortices) as well
as contralateral or long-distance areas (e.g., frontal cortex,
somatosensory regions, posterior parietal cortex) and subcortical
areas (anterior cingulate cortex) in healthy controls (Lang et al.,
2005; Kwon et al., 2008; Kim et al., 2012). These areas are
altered in chronic pain syndromes (Baliki et al., 2011). Yoon
et al. (2014) used PET-scan to assess brain metabolism after
M1 tDCS in participants with chronic pain. They reported
that tDCS induces increased metabolism in the medulla and
decreased metabolism in the left DLPFC (Yoon et al., 2014).
These various neuroimaging studies demonstrate the effect of M1
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tDCS on cortical and sub-cortical pain-related network activity.
New multichannel-tDCS devices may be even more effective
given that they could target and stimulate different areas involved
in the same neural network. Preliminary mechanistic studies
have shown the superiority of such approaches as compared
to conventional dual tDCS (Fischer et al., 2017). Indeed, it
has been demonstrated that, as compared to conventional
M1 tDCS montage, a single session of novel eight-electrode
montage targeting M1 and its associated network induced more
than twice as much increase in M1 excitability, measured by
resting state fMRI (Fischer et al., 2017). This result shows the
possible superiority of such novel network-based multi-channel
tDCS approaches; however, behavioral effects still need to be
demonstrated.
When discussing multi-channel tDCS protocols, it is essential
to stress the importance of the polarity and electrode montage,
together with the optimal current intensity. For instance, in an
experiment aiming at studying the effect of increasing current
intensities on cortical excitability, Batsikadze et al. (2013),
showed that, while cathodale tDCS applied at 1mA reduced
cortical excitability, increasing the intensity to 2mA induced
opposite effects (i.e., enhancement of cortical excitability). These
results suggest that increasing the intensity of stimulation does
not necessarily strengthen the effects but, on the contrary, can
result in a shift of the direction of expected cortical changes.
To help clinicians and researchers to test and validate optimal
electrodes montage and current parameters before running an
experiment, computer-based model of the electrical field should
be explored, such as demonstrated recently in several studies
(Kessler et al., 2013; Gillick et al., 2014; Galletta et al., 2015).
Regarding the selection of the main outcome measure(s),
especially when it concerns clinical scales, it is of an upmost
importance to choose a sensitive tool that accurately evaluates the
symptoms being treated and/or the mechanisms of the therapy.
In our case, the mental states evaluated by the selected scales
(i.e., QoL and SWLS) are unrelated to modulation of the motor
cortex excitability. The expected improvements would have been
related to the indirect effects of pain relief on patients’ quality
of life and satisfaction. Despite the fact that many studies have
demonstrated a correlation between pain levels and quality of life
(Wahl et al., 2009; Scholich et al., 2012; Wranker et al., 2014),
it cannot be assumed that a novel treatment for pain will also
effectively treat associated secondary manifestations. This brings
us to another factor critical to be considered when analyzing the
results of a trial. The fact that no improvements were noticed
on secondary outcomes does not conclusively demonstrate that
the intervention is ineffective for such symptoms. Indeed, a
trial is designed based on the primary outcome measure. The
protocol design, sample size calculation, follow-up measures, or
the chronology of the tests are all factors that are elaborated
based on the research question and the main goal of a study.
For instance, it is possible that our study was not sufficiently
powered to detect changes in QoL or life satisfaction. Other
scales, such as the SF-36 (36-Item Short Form Survey, assessing
mental state based on patients’ report; McHorney et al., 1993)
may have been more sensitive to detect changes since they may
be more impacted by pain. Similarly, the effects we found in pain
scores in our trial may not have been strong enough to modify
other related outcomes. In addition, to observe improvement
on mental states, especially in individuals with chronic pain, a
greater and more prolonged effect on pain may be required,
and therefore, more tDCS sessions may be needed to induce
significant quality of life enhancements. It is also important
to objectively analyze the (negative) results and explain such
findings, while avoiding over-concluding if the pre-specified
hypothesis is not met. To conclude, we here aimed to emphasize
the importance of network selection when designing a clinical
trial on tDCS effects. This requires a good understanding of the
mechanisms underlying the symptoms to treat and the neural
adaptation occurring in the related condition. For chronic pain,
evidence suggests that pain is associated with the phenomenon
of central sensitization involving a large neural network that
includes limbic structures, such as the anterior cingulate cortex,
hippocampus and amygdala, and thalamic nuclei, as well as
the sensorimotor area (Treede et al., 1999; Phillips and Clauw,
2011; Bourke et al., 2015). In addition, enhanced activity in
pain-related brain structures have been reported, including the
motor cortex (Fregni et al., 2006a). By targeting an area that
is linked to pain circuitry, we expected to observe significant
effects of tDCS on pain level as measured by the visual
analog scale (VAS) and we confirm our hypothesis. Similar
symptoms-network-outcome pyramidal approach needs to be
applied when designing a clinical trial on neuromodulation.
Moreover, behavioral intervention(s) targeting the same cortical
network should be tested in addition to tDCS in order to prime
its effects.
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